Capital International’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$56.8M Buy
127,607
+15,061
+13% +$6.71M 2.18% 7
2025
Q1
$54.6M Buy
112,546
+1,975
+2% +$958K 2.38% 8
2024
Q4
$44.5M Buy
110,571
+10,966
+11% +$4.42M 1.82% 9
2024
Q3
$46.3M Sell
99,605
-866
-0.9% -$403K 2% 8
2024
Q2
$47.1M Buy
100,471
+915
+0.9% +$429K 2.17% 7
2024
Q1
$41.6M Buy
99,556
+14,680
+17% +$6.14M 1.99% 8
2023
Q4
$34.5M Buy
84,876
+3,377
+4% +$1.37M 1.77% 7
2023
Q3
$28.3M Buy
81,499
+1,259
+2% +$438K 1.63% 10
2023
Q2
$28.2M Buy
80,240
+10,527
+15% +$3.7M 1.58% 8
2023
Q1
$22M Buy
69,713
+4,258
+7% +$1.34M 1.32% 14
2022
Q4
$18.9M Sell
65,455
-5,395
-8% -$1.56M 1.3% 17
2022
Q3
$20.5M Buy
70,850
+7,483
+12% +$2.17M 1.43% 12
2022
Q2
$17.9M Buy
63,367
+111
+0.2% +$31.3K 1.34% 13
2022
Q1
$16.5M Sell
63,256
-20,335
-24% -$5.31M 0.94% 26
2021
Q4
$18.4M Buy
83,591
+10,036
+14% +$2.2M 0.93% 24
2021
Q3
$13.3M Sell
73,555
-12,473
-14% -$2.26M 0.73% 38
2021
Q2
$17.3M Buy
86,028
+6,144
+8% +$1.24M 0.96% 25
2021
Q1
$17.2M Sell
79,884
-1,275
-2% -$274K 1.04% 21
2020
Q4
$19.2M Sell
81,159
-1,091
-1% -$258K 1.12% 21
2020
Q3
$22.4M Buy
82,250
+16,221
+25% +$4.41M 1.52% 14
2020
Q2
$19.2M Buy
66,029
+3,004
+5% +$872K 1.79% 13
2020
Q1
$15M Buy
+63,025
New +$15M 1.68% 13
2018
Q3
Sell
-6,831
Closed -$1.16M 167
2018
Q2
$1.16M Buy
6,831
+797
+13% +$135K 0.2% 117
2018
Q1
$983K Buy
+6,034
New +$983K 0.18% 126